Kestra Advisory Services, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Kestra Advisory Services, LLC
- $14.4 Billion
- Q1 2024
A detailed history of Kestra Advisory Services, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 14,500 shares of LXRX stock, worth $24,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,500Holding current value
$24,360% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
122Shares Held
159MCall Options Held
2.11MPut Options Held
412K-
Artal Group S.A. Luxembourg, N4118MShares$197 Million15.21% of portfolio
-
Black Rock Inc. New York, NY7.69MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.4MShares$10.8 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.95 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA2.39MShares$4.01 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $317M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...